Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

Meir Medical Center207 enrolled

Overview

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies. The investigators believe that minor antibodies have a major role in the hypercoagulability state.

Study Type

OBSERVATIONAL

Enrollment

207

Conditions

Ischemic Stroke

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * stroke diagnosis * blood sampling within 36hrs from the event * written agreement Exclusion Criteria: * a stroke, MI or major operation prior to the current stroke * hypercoagulable state known in this patient * a severe chronic disease known at the time of the stroke * an infection on arrival (based on anamnesis, physical exam and lab tests) * thrombolytic treatment

Locations (1)

Meir health center

Kfar Saba, Israel

Central Contacts

Yair Levy, Prof.

CONTACT

0533671735 levy.yair@clalit.org.il,

Narin N Carmel, B.Sc

CONTACT

0547691482 carmeln@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.